,uuid,title,publisher,link,providerPublishTime,type
0,6d2c22e1-1559-3abb-80d2-07f1c0fb989c,Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio,Zacks,https://finance.yahoo.com/news/why-1-momentum-stock-could-142602810.html,1648045562,STORY
1,415d9a5b-2ead-3271-bb37-f330ec57335e,Catalent's (CTLT) New Project Completion Expands Global Footprint,Zacks,https://finance.yahoo.com/news/catalents-ctlt-project-completion-expands-164704223.html,1647881224,STORY
2,534a0560-701d-37c4-bf1c-a9c9a038b042,"Catalent, Inc. to Present at the KeyBanc Life Sciences & MedTech Investor Forum",Business Wire,https://finance.yahoo.com/news/catalent-inc-present-keybanc-life-123000896.html,1647606600,STORY
3,84261de0-052a-32ec-bd96-81b4764b45f8,"Catalent, Inc. (NYSE:CTLT) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?",Simply Wall St.,https://finance.yahoo.com/news/catalent-inc-nyse-ctlt-stock-143458520.html,1647354898,STORY
4,ae7ab0e8-1447-3266-90a9-62f8f21b6d7b,Catalent Publishes Third Annual Corporate Responsibility Report,Business Wire,https://finance.yahoo.com/news/catalent-publishes-third-annual-corporate-133000622.html,1646919000,STORY
5,90c018b6-6434-3f28-b4c5-b646b94bb7e3,Reasons to Retain Catalent (CTLT) Stock in Your Portfolio,Zacks,https://finance.yahoo.com/news/reasons-retain-catalent-ctlt-stock-164904354.html,1646844544,STORY
6,370a7374-eedd-337b-a110-75e7bdbfd133,Catalent's (CTLT) New Tie-Up to Provide Better Patient Access,Zacks,https://finance.yahoo.com/news/catalents-ctlt-tie-better-patient-151603557.html,1646666163,STORY
7,8ebd1b97-f208-3721-a4e2-872ffebc7c44,Catalent (CTLT) Down 3.4% Since Last Earnings Report: Can It Rebound?,Zacks,https://finance.yahoo.com/news/catalent-ctlt-down-3-4-163004210.html,1646325004,STORY
